baber/WOPTO huggingface dataset:
Patent AU-667976-B2 (AU)
Title: Flat glass furnaces
Inventor: QUIRK RICHARD
IPC: C03B5/04
Filed: 1993-11-17
Granted: 1996-04-18
Abstract: A method of operating a regenerative glass furnace (10) for melting flat glass so as to minimise emission of carbon monoxide (CO) in waste gases leaving the furnace (10), the furnace (10) including a melting chamber (12) and regenerators (13,14) which act as heat exchangers, each regenerator (13,14) containing a checkerwork structure (15,15'), the method comprising providing air and supplying fuel to the melting chamber (12) of the furnace (10) to ensure that glass of a required quality at a required production rate is obtained, characterised in that the regenerators (13,14) are sealed and fuel in excess of that required to ensure the glass quality and production rate is supplied at least to the melting chamber (12) or the sealed regenerators (13,14) such that the waste gases in the sealed regenerators (13,14) contain combustible material including CO, and removing the CO from the waste gases in the regenerators (13,14) by combusting CO downstream of the checkerwork structure (15,15') of the regenerators (13,14) at a temperature of greater than about 650 DEG C. <IMAGE>
Patent AU-751179-B2 (AU)
Title: Arrangement for controlling rock drilling
Inventor: POYSTI TAPANI
IPC: E21B1/26
Filed: 1999-08-05
Granted: 2002-08-08
Abstract: The invention concerns an arrangement for controlling a hydraulic rock drilling device. The arrangement includes a pressure ratio valve that is used for adjusting the relation between the pressures in the pressure channel leading to the percussion device and/or another actuator, such as a shank stabilizer, and the pressure channel leading to the feed mechanism. The pressure ratio valve is arranged to keep the relation between the pressures of the actuator and the feed mechanism constant over the normal drilling range.
Patent AU-715621-B2 (AU)
Title: TIE-2 ligands, methods of making and uses thereof
Inventor: DAVIS SAMUEL
IPC: G01N33/15
Filed: 1996-04-05
Granted: 2000-02-03
Abstract: The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptorbody which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention further provides for a ligandbody which specifically binds TIE-2 receptor. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth, differentiation or migration of cells expressing the TIE-2 receptor, including, but not limited to, hematopoietic precursor cells, a method of blocking the growth, differentiation or migration of cells expressing the TIE-2 receptor including, but not limited to, hematopoietic precursor cells, and a method of attenuating or preventing tumor growth in a human.
Patent AU-667764-B2 (AU)
Title: Olefin polymer films
Inventor: GIACOBBE JAMES
IPC: C08J5/18
Filed: 1994-02-16
Granted: 1996-04-04
Abstract: A film or sheet material 95-60 wt. % heteroplastic olefin polymer compsn. (I) and 5-40 wt. % of an ethylene alpha-olefin copolymer (II) of density 0.890-0.940 g/cc in which the alpha-olefin is of formula CH2=CHR (R = 1-8C alkyl). The heteroplastic olefin polymer compsn. (I) comprises 10-50 wt. % propylene polymer (III), 5-20 wt. % semi-crystalline linear copolymer fraction (IV) and 40-80 wt. % xylene-soluble copolymer fraction (V). (III) has an isotactic index greater than 80 and is propylene homopolymer or a copolymer contg. over 80 wt. % propylene with ethylene and/or a 4-10C alpha-olefin. (IV) has a crystallinity of 20-60 % and is insoluble in xylene at room temp. (IV) is a copolymer of ethylene and propylene contg. over 55 wt. % ethylene, or a copolymer of ethylene, propylene and 1-10 wt. % 4-10C alpha-olefin in which the combined content of ethylene and 4-10C alpha-olefin is over 55 wt. %, as a copolymer of ethylene and a 4-10C alpha olefin contg. over 55 wt. % 4-10C alpha-olefin. (V) has a intrinsic viscosity of 1.5-4.0 dl/g and is a copolymer of ethylene and propylene contg. 20-40 wt. % ethylene at a copolymer of ethylene, propylene and 1-10 wt. % 4-10C alpha-olefin in which the combined content of ethylene and 4-10C alpha-olefin is 20-40 wt. % or a copolymer of ethylene, 4-10C alpha-olefin and opt. 0.5-10 wt. %, diene, in which the 4-10C alpha-olefin content is 20-40 wt. %. The wt. ratio of (IV):(V) is less than 0.4:1. (I) is prepd. by polymerisation in at least 2 stages.
Patent AU-770780-B2 (AU)
Title: Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
Inventor: VOGELS RONALD
IPC: A61K48/00
Filed: 1999-11-22
Granted: 2004-03-04
Abstract: The invention provides a nucleic acid delivery vehicle with or having been provided with at least a tissue tropism for smooth muscle cells and/or endothelial cells. In one aspect said nucleic acid delivery vehicle is a virus capsid or a functional part, derivative and/or analogue thereof. Preferably said virus capsid is an adnovirus capsid. Preferably said adenovirus is a subgroup B adenovirus, preferably adenovirus 16. Preferably said tissue tropism is provided by at least a tissue tropism determining part of an adenovirus fiber protein or a functional derivative and/or analogue thereof. The invention further presents methods for the treatment of diseases, preferably cardiovascular diseases.
Patent AU-591154-B2 (AU)
Title: Refrigeration system for a counter-top or wall-mounted vending machine
Inventor: MORGAN ANNIS RAY JR
IPC: G07F11/30
Filed: 1986-08-06
Granted: 1989-11-30
Abstract: A coin-operated vending machine for bottles or cans of a moderate capacity, including a plurality of side-by-side storage chutes for feeding bottles or cans to openings in the front wall of the vending machine and a cradle in each of the openings forming a row of adjacent cradles for receiving the bottles or cans from the chutes. A refrigeration system directs chilled air by convection toward the next-to-be-vended cans in each of the cradles. The chilled air is directed by an air foil toward the cradles and the cradles have stand-off ribs therein to permit the free flow of chilled air under and around the next-to-be-vended cans.
Patent AU-776808-B2 (AU)
Title: Lavatory cleansing block
Inventor: SIDGWICK IAN
IPC: C11D3/02
Filed: 1999-10-19
Granted: 2004-09-23
Abstract: A lavatory cleansing block has two parts co-extruded together, the first part containing a chlorine releasing bleach and the second part containing component such as a perfume or colorant which need not be bleach resistant. Migration of components is avoided if there is no common hydrophobe in the two parts. The perceived performance of the perfume is enhanced by its juxtaposition with the bleach.
Patent AU-538651-B2 (AU)
Title: Manufacture of thermoplastics pipe
Inventor: ASTON WILLIAM CHARLES
IPC: B29C65/00
Filed: 1980-09-11
Granted: 1984-08-23
Abstract: Apparatus for use in the manufacture of socketed thermoplastics pipe by the radial expansion of a pipe blank. The apparatus includes an openended central mould portion 12 which can be raised or lowered on stanchions 10, 11 to three predetermined positions: a pair of mould end portions 15, 17 each having a supporting mandrel 19, 20 engageable with the pipe blank 28, end portions 15, 17 being advanceable to and retractable from the central mould portion 12. One of the mould end portions 15 is internally contoured to provide part of the socket-forming portion of the mould. The mould end portions 15, 17 can be held in an intermediate position, partially advanced towards the central portion 12 to locate the blank 28 on mandrels 19, 20 before closing of the mould.
Patent AU-577206-B2 (AU)
Title: Conjugates of vinblastine and protein
Inventor: TROUET ANDRE BENOIT LENON
IPC: A61K31/395
Filed: 1986-09-30
Granted: 1988-09-15
Abstract: Previously unknown conjugates of vinblastine, or derivatives thereof, have the general formula <IMAGE> where A denotes an "arm" such as <IMAGE> or <IMAGE> where n is an integer from 1-5 and R is a hydrogen atom or an acyl group, R1 is an optionally modified protein radical, R2 is a methoxy group, an amino group or an α-amino acid ester which is bonded using a bond of the amide type and where the ester group contains 1-6 carbon atoms, and where R3 is a hydrogen atom or an hydroxyl group and is in all cases in the two possible configurations. These conjugates have a powerful effect when treating leukaemias, lymphosarcomas and other malignant tumours, including the so-called "solid" tumours, and when treating Hodgkin's disease.
Patent AU-659975-B2 (AU)
Title: An apparatus for releasing a self-expanding endoprosthesis
Inventor: LUKIC GORAN
IPC: A61F2/966
Filed: 1994-05-30
Granted: 1995-06-01
Abstract: The assembled endoprosthesis is in a radially tensioned state in a cylindrical space (14) and lies with a proximal region (A) in a first external catheter (3) and with a distal region (B) in a second external catheter (30). In order to release the endoprosthesis (1), for example in a vessel (11), the second external catheter (30) is initially retracted. The endoprosthesis (1) is then still retained in the first external catheter (3) by friction and can be folded back by advancing the second external catheter (30), and can thus be repositioned. The endoprosthesis (1) is finally released by retracting the first external catheter (3). Since the friction is divided up over at least two external catheters (3, 30) it is also possible to release endoprostheses (1) which have a high friction on the outside to the external catheter, for example due to a coating, high expansion force or large length. <IMAGE>
Patent AU-764189-B2 (AU)
Title: Method for producing L-amino acid
Inventor: LIVSHITS VITALIY ARKADIEVICH
IPC: C12N15/11
Filed: 1999-12-13
Granted: 2003-08-14
Abstract: A bacterium belonging to the genus Escherichia and having an ability to produce an L-amino acid, wherein the ability to produce the L-amino acid is increased by increasing an expression amount of an L-amino acid excretion protein, and a method for producing the L-amino acid using the bacterium.
Patent AU-632394-B2 (AU)
Title: Thermoplastic polyester series resin foamed material and production process thereof
IPC: C08L67/02
Filed: 1990-12-27
Granted: 1992-12-24
Abstract: A thermoplastic polyester series foamed material having a thickness of at least 3 mm and an apparent density of from 0.05 to 0.7 g/cm<3> is diclosed, wherein the crystallinity of the resin in the surface portion within 0.5 mm from the surface of the foamed material is not more than 30% and at least 1% lower than the crystallinity of the resin in the central portion of the foamed material.
Patent AU-686634-B2 (AU)
Title: Apparatus and methods for intraluminal photothermoforming
Inventor: PATHAK CHANDRASHEKHAR P
IPC: A61F2/00
Filed: 1994-04-28
Granted: 1998-02-12
Abstract: A method and apparatus for molding polymeric structures in vivo is disclosed. The structures comprise polymers that may be heated to their molding temperature by absorption of visible or near-visible wavelengths of light. By providing a light source that produces radiation of the wavelength absorbed by the polymeric material, the material may be selectively heated and shaped in vivo without a corresponding heating of adjacent tissues or fluids to unacceptable levels. The apparatus comprises a catheter having a shaping element positioned near its distal end. An emitter provided with light from at least one optical fiber is positioned within the shaping element. The emitter serves to provide a moldable polymeric article positioned on the shaping element with a substantially uniform light field, thereby allowing the article to be heated and molded at a desired treatment site in a body lumen.
Patent AU-602883-B2 (AU)
Title: Assays for myasthenia gravis and substrates and kits for use therein
Inventor: LINDSTROM JON MARTIN
IPC: G01N33/564
Filed: 1987-01-05
Granted: 1990-11-01
Abstract: Improved assays are provided for anti-acetylcholine receptor protein autoantibodies in the sera of patients with myasthenia gravis. The basis for the improved assays is the discovery that large quantities of acetylcholine receptor protein, that, for practical purposes in immunoassays, is immunologically indistinguishable from human muscle acetylcholine receptor protein, can be isolated from cells of the human medullablastoma-derived cell line TE671.
Patent AU-538033-B2 (AU)
Title: Microwave oven door having a conformable screen
Inventor: BIRK EARL
IPC: F24C15/04
Filed: 1981-06-23
Granted: 1984-07-26
Abstract: A microwave oven having a door configured to minimize the leakage of microwave energy is disclosed. The door includes a flat sheet of glass and a flexible metal screen substantially overlying the glass sheet. The glass and the metal screen are held in substantially coplanar relationship in a frame. The edges of the metal screen are deformed such that the mounting of the metal screen in the frame causes the central portion of the metal screen to bow away from the glass. When the door is closed the metal screen conforms to the oven front panel.
Patent AU-538764-B2 (AU)
Title: Manufacture of printing forms or printed circuits
Inventor: LIND ERWIN
IPC: G03G13/26
Filed: 1981-06-26
Granted: 1984-08-23
Abstract: This invention relates to an improvement in the process for the manufacture of printing forms and printed circuits by coating an electrically conductive support with an organic photoconductor layer and by charging, exposing, and developing the electrostatic image by means of a finely particulate toner, fixing and dissolving the layer away from the non-image areas by means of a decoating medium and, if appropriate, etching of the bared support surface, the improvement which comprises, for the purpose of coating, transferring the organic photoconductor layer on a temporary support to the electrically conductive support with the aid of heat and pressure.
Patent AU-677093-B2 (AU)
Title: Method of stabilizing preparations for contact lenses
Inventor: NAKAYAMA HISAYUKI
IPC: C11D3/00
Filed: 1994-09-30
Granted: 1997-04-10
Abstract: Pyrrolidone compounds stabilize proteolytic enzymes in aqueous solution and hence are useful in contact lens cleaning preparations containing proteolytic enzymes. Preferably, the preparations also contain a surfactant.
Patent AU-548162-B2 (AU)
Title: Storage drawer locks
Inventor: AMBAUM PETER ANTONIUS MARIE
IPC: E05B65/46
Filed: 1981-08-31
Granted: 1985-11-28
Abstract: An assembly of storage units (6,7) which are mainly used in offices for a well-ordered filing of documents, will appear to be too small after some time. If one adds a column of units, this will have a lock of its own. The invention provides an assembly whereof some or all units of some or all columns can be locked by one locking mechanism. In the case of storage units consisting of a case with inwardly directed flanges cooperating with side flanges of drawers, each column has a converting mechanism (11) which is not only responsible for the up and down movements of lock rods but also for the reciprocating movement of a coupling rod (12) whose other end can cooperate with the converting mechanism of adjacent columns.
Patent AU-646032-B2 (AU)
Title: Selective processes for fosinopril polymorphs
Inventor: GROSSO JOHN A
IPC: A61P9/12
Filed: 1991-04-23
Granted: 1994-02-03
Abstract: Described herein is a process for selectively preparing and interconverting polymorph salts of fosinopril, an antihypertensive agent that inhibits angiotensin converting enzyme. Each polymorph is prepared by mixing an alkali metal carrier, fosinopril, water and a keto and/or hydroxylic solvent and isolating the polymorph formed from the reaction mixture. The less exothermic polymorph A is formed when the water makes up more than about 0.2% of the water and solvents; at about 0.2% or less, the more exothermic polymorph B is formed. <IMAGE>
Patent AU-723016-B2 (AU)
Title: Viral inactivation treatment of red blood cells using phthalocyanines and red light
Inventor: BEN-HUR EHUD
IPC: A61K41/00
Filed: 1996-11-04
Granted: 2000-08-17
Abstract: PCT No. PCT/US96/17528 Sec. 371 Date Sep. 1, 1998 Sec. 102(e) Date Sep. 1, 1998 PCT Filed Nov. 4, 1996 PCT Pub. No. WO97/16966 PCT Pub. Date May 15, 1997Disclosed are two processes. The first process involves treating a red blood cell-containing composition to inactivate an extracellular or intracellular virus which may be present in said red blood cell-containing composition by subjecting said red blood cell-containing composition to a virucidally effective amount of a phthalocyanine and red light, wherein the improvement involves (i) determining the action spectrum of said phthalocyanine for causing inactivation of said virus; (ii) determining the action spectrum of said phthalocyanine for causing red blood cell damage; (iii) comparing (i) and (ii), and, if (i) and (ii) are not identical then determining the wavelength at which the largest favorable difference exists between (i) and (ii); (iv) providing a red light source emitting red light only in 10 nm in either direction of the wavelength determined in (iii); and then (v) subjecting said red blood cell-containing composition to said virucidally effective amount of said phthalocyanine and said provided red light source. In a preferred embodiment, the phthalocyanine is Pc 4, which has the formula: HOSiPcOSi(CH3)2(CH2)3N(CH3)2. The second process involves transfusing red blood cells to a patient in need thereof by withdrawing red blood cells from a donor, subjecting the red blood cells to the first process and transfusing the red blood cells to said patient.
Patent AU-593673-B2 (AU)
Title: Pigment composition
Inventor: NAKAMURA MICHIEI
IPC: C09D7/45
Filed: 1987-08-10
Granted: 1990-02-15
Abstract: A pigment composition contains a pigment and a dispersant. The dispersant is a phosphoric ester compound represented by the following general formula: <CHEM> wherein at least one of the three Rs is a residuum of a polyester chain containing as principal bonds thereof ester bonds of a polycarboxylic acid and a polyalcohol.
Patent AU-666829-B2 (AU)
Title: Bronze glass composition
Inventor: KRUMWIEDE JOHN FRANKLIN
IPC: C03C1/10
Filed: 1994-11-08
Granted: 1996-02-22
Abstract: The present invention provides a glass composition having a bronze color and a luminous (visible) transmittance of 70% or greater. The base glass is a soda-lime-silica composition and iron and selenium are added as colorants. In one particular embodiment of the invention, a bronze colored glass with a luminous transmittance (C.I.E. illuminant A) of 70% and higher at a thickness of 4.1 millimeters may be attained by using as colorants: 0.38 to 0.48 wt. % Fe2O3, up to 0.13 wt. % FeO and 3 to 15 PPM Se, and preferably 0.395 to 0.465 wt. % Fe2O3, 0.075 to 0.12 wt. % FeO and 6 to 12 PPM Se. In addition, it is preferred that the total solar energy transmittance be no greater than 65%.
Patent AU-674616-B2 (AU)
Title: Methods for the spray application of water-borne coatings with compressed fluids
Inventor: NIELSE KENNETH ANDREW
IPC: C09D201/00
Filed: 1994-09-27
Granted: 1997-01-02
Abstract: The present invention is directed to methods for spraying water-borne coating compositions having at least about thirty five percent by weight of the solvent fraction by using compressed fluids such as carbon dioxide and ethane, so as to decrease runs, sags and drying time in the application of coatings.
Patent AU-650031-B2 (AU)
Title: 1-Piperidinyl alkanoylarylsulfonamide derivatives
Inventor: CARR ALBERT A
IPC: A61K31/451
Filed: 1991-05-15
Granted: 1994-06-09
Abstract: The present invention is direct to a new class of 1-piperidinyl alkanoylarylsulfonamides and their use as antiarrhythmic agents.
Patent AU-603161-B2 (AU)
Title: Detection of necrotic malignant tissue and associated therapy
Inventor: EPSTEIN ALAN L
IPC: A61K51/00
Filed: 1987-12-03
Granted: 1990-11-08
Abstract: Disclosed is a method for measuring the effectiveness of therapy intended to kill malignant cells in vivo in a mammal, comprising the steps of obtaining monoclonal antibody that is specific to an internal cellular component of the mammal but not to external cellular components, wherein the monoclonal antibody is labeled; contacting the labeled antibody with tissue of a mammal that has received therapy to kill malignant cells in vivo and determining the effectiveness of the therapy by measuring the binding of the labeled antibody to the internal cellular component. The internal cellular component is preferably insoluble intracellular antigen, and the label is preferably a radionuclide, a radiopaque material, or a magnetic resonance-enhancing material. Also disclosed is a method whereby the antibody to insoluble intracellular antigen is conjugated to an antineoplastic agent, so that upon administration of the antibody-antineoplastic agent conjugate, antineoplastic agent may be delivered to the tumor. Also disclosed are antibodies for use with the foregoing methods.
Patent AU-659618-B2 (AU)
Title: Nozzle assembly for preventing back-flow
Inventor: DUNNE STEPHEN TERENCE
IPC: B05B7/00
Filed: 1991-12-04
Granted: 1995-05-25
Abstract: PCT No. PCT/GB91/02147 Sec. 371 Date Jun. 4, 1993 Sec. 102(e) Date Jun. 4, 1993 PCT Filed Dec. 4, 1991 PCT Pub. No. WO92/10306 PCT Pub. Date Jun. 25, 1992.A nozzle assembly which comprises a nozzle aperture for discharge of a fluid as a spray of droplets, and a conduit in fluid flow communication with the nozzle aperture. The flow of fluid through the conduit is restricted by the minimum effective cross-sectional area of the conduit transverse to the line of flow of fluid through the conduit so that back flow of fluid from the nozzle aperture through the conduit at ambient and operational pressure differentials is substantially prevented. The invention further provides for a method of discharging a fluid as a spray of droplets, and a spray generating device which includes the nozzle assembly of the present invention.
Patent DE-2029630-B2 (DE)
Title: Pilot tone monitor for carrier frequency systems - has successive gain adjustment via flip=flops from low to high gain with specified adjustment for instances of missing pilot
IPC: H04B3/10
Filed: 1970-06-16
Abstract: The pilot tone monitor circuit for carrier frequency transmission systems comprises a level detector, regulator and alarm circuit (PR) with four terminal points (VE1-2, AA-AB). A single transistor stage (TSV) operates as a presetting device with a zener diode in its base circuit. Two further transistors are connected as a bistable circuit (TS1-2). The regulating system is initially set to a relatively low order of gain, and then is successively adjusted to higher gain. If the pilot tone fails, the regulator is set so that the gain exceeds and is then maintained at the difference between the setting range middle value and the alarm level/average value difference. The flip-flop is self-interrogating so that this regulator setting is detected.
Patent DE-2031527-B2 (DE)
Title: Automatic torque limiter system - stops drive when torque exceeds max. and has cam urging rollers against stationary ring
IPC: F16D43/208
Filed: 1970-06-25
Abstract: A torque limiter has coaxial input and output members (10, 12) connected by a torsion spring (14) which transmits torque between the members. The input member (10) has a peripheral array of cam lobes surmounted by respective rollers (11) lying in a cage secured to the output member (12). The spring allows the torque to produce relative angular movement between the members. This in turn causes cams to move the rollers and toward a stationary ring (13). When the torque attains a gi en maximum the rollers engage the ring and then cooperate with the cams to arrest the rotation of the input member.